Beaconlight Capital, LLC Care Dx, Inc. Transaction History

Beaconlight Capital, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 16, 2020	SELL	$30.88 - $37.94 $3.87 Million - $4.76 Million	-125,403 Closed	0 $0
Q2 2020 Aug 14, 2020	SELL	$18.95 - $35.43 $245,004 - $458,074	-12,929 Reduced 9.35%	125,403 $4.44 Million
Q1 2020 May 15, 2020	BUY	$13.94 - $28.25 $868,685 - $1.76 Million	62,316 Added 81.98%	138,332 $3.02 Million
Q4 2019 Feb 14, 2020	BUY	$19.24 - $28.41 $1.03 Million - $1.53 Million	53,716 Added 240.88%	76,016 $1.64 Million
Q3 2019 Nov 14, 2019	BUY	$20.03 - $40.08 $446,669 - $893,784	22,300 New	22,300 $504,000
Q4 2018 Feb 14, 2019	SELL	$19.89 - $30.02 $5.14 Million - $7.75 Million	-258,276 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$12.1 - $28.85 $3.13 Million - $7.45 Million	258,276 New	258,276 $7.45 Million

215

50.9M

97.3K

43.3K

Ticker CDNA
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 53,458,100
Market Cap $1.25B
Description
CareDx, Inc. discovers, develops, and commercializes diagnostic solutions for transplant patients and caregivers worldwide. It provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for...

Get notified when there are updates to the investment portfolio of Beaconlight Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Beaconlight Capital, LLC with notifications on news.